Pune, India – May 28, 2025 – The global MRI Guided Neurosurgical Ablation Market is experiencing significant growth, fueled by rising demand for minimally invasive neurosurgical procedures, enhanced imaging accuracy, and strategic industry collaborations. According to Quintile Reports, the market is poised to grow robustly over the next decade, driven by increased incidence of neurological disorders, technological breakthroughs, and expanding applications in oncology and functional neurosurgery.
Market Overview
MRI-guided neurosurgical ablation enables precise targeting of brain tissues without the need for traditional open surgery, offering a safer and more efficient solution for patients with conditions such as epilepsy, glioblastoma, and Parkinson’s disease. The integration of real-time imaging and robotics continues to redefine the neurosurgical landscape, leading to shorter recovery times, reduced risks, and improved patient outcomes.
The market’s growth is being bolstered by rising adoption in hospitals and research centers, particularly across North America and Europe, with Asia-Pacific emerging as a fast-growing region due to improved healthcare infrastructure and investments in medical imaging technologies.
Key Strategic Initiatives
Several companies have launched strategic initiatives to strengthen their positions in the MRI-guided ablation space:
- Monteris Medical, a pioneer in laser ablation systems, continues to expand its footprint with its NeuroBlate® System, widely adopted for treating brain tumors and epileptogenic foci.
- Medtronic is investing in next-generation neuro-ablative systems, combining MRI precision with robotic-assisted navigation for safer tumor resections.
- InSightec, known for its Exablate Neuro platform, secured additional FDA approvals in 2024 for expanded indications, including essential tremor and Parkinson’s-related tremors.
Recent Merger & Acquisition Activity
In 2024, a landmark acquisition reshaped the competitive landscape when Siemens Healthineers acquired the Israeli neurotech firm Rapid Medical in a deal valued at USD 350 million. This merger is expected to accelerate innovation in real-time MRI visualization and integrate AI for intraoperative decision support.
Similarly, Philips Healthcare entered into a strategic collaboration with ClearPoint Neuro to jointly develop AI-enhanced MRI navigation tools for laser interstitial thermal therapy (LITT), further strengthening their capabilities in minimally invasive neurosurgery.
Market Outlook
The MRI Guided Neurosurgical Ablation Market is forecasted to reach unprecedented valuations by 2034, with a projected CAGR of over 11.5%. Innovations in AI-guided surgical planning, portable MRI systems, and neuromodulation platforms are expected to unlock new opportunities across emerging economies.
About Quintile Reports
Quintile Reports is a trusted global provider of market intelligence, delivering deep industry insights, accurate forecasting, and strategic advisory across the healthcare, technology, and industrial sectors. With a comprehensive research methodology and access to real-time data, we empower businesses to make informed decisions in competitive environments.
Pune, India – May 28, 2025 – The global MRI Guided Neurosurgical Ablation Market is experiencing significant growth, fueled by rising demand for minimally invasive neurosurgical procedures, enhanced imaging accuracy, and strategic industry collaborations. According to Quintile Reports, the market is poised to grow robustly over the next decade, driven by increased incidence of neurological disorders, technological breakthroughs, and expanding applications in oncology and functional neurosurgery.
Market Overview
MRI-guided neurosurgical ablation enables precise targeting of brain tissues without the need for traditional open surgery, offering a safer and more efficient solution for patients with conditions such as epilepsy, glioblastoma, and Parkinson’s disease. The integration of real-time imaging and robotics continues to redefine the neurosurgical landscape, leading to shorter recovery times, reduced risks, and improved patient outcomes.
The market’s growth is being bolstered by rising adoption in hospitals and research centers, particularly across North America and Europe, with Asia-Pacific emerging as a fast-growing region due to improved healthcare infrastructure and investments in medical imaging technologies.
Key Strategic Initiatives
Several companies have launched strategic initiatives to strengthen their positions in the MRI-guided ablation space:
- Monteris Medical, a pioneer in laser ablation systems, continues to expand its footprint with its NeuroBlate® System, widely adopted for treating brain tumors and epileptogenic foci.
- Medtronic is investing in next-generation neuro-ablative systems, combining MRI precision with robotic-assisted navigation for safer tumor resections.
- InSightec, known for its Exablate Neuro platform, secured additional FDA approvals in 2024 for expanded indications, including essential tremor and Parkinson’s-related tremors.
Recent Merger & Acquisition Activity
In 2024, a landmark acquisition reshaped the competitive landscape when Siemens Healthineers acquired the Israeli neurotech firm Rapid Medical in a deal valued at USD 350 million. This merger is expected to accelerate innovation in real-time MRI visualization and integrate AI for intraoperative decision support.
Similarly, Philips Healthcare entered into a strategic collaboration with ClearPoint Neuro to jointly develop AI-enhanced MRI navigation tools for laser interstitial thermal therapy (LITT), further strengthening their capabilities in minimally invasive neurosurgery.
Market Outlook
The MRI Guided Neurosurgical Ablation Market is forecasted to reach unprecedented valuations by 2034, with a projected CAGR of over 11.5%. Innovations in AI-guided surgical planning, portable MRI systems, and neuromodulation platforms are expected to unlock new opportunities across emerging economies.
About Quintile Reports
Quintile Reports is a trusted global provider of market intelligence, delivering deep industry insights, accurate forecasting, and strategic advisory across the healthcare, technology, and industrial sectors. With a comprehensive research methodology and access to real-time data, we empower businesses to make informed decisions in competitive environments.
Secure Payment
-
A license granted to one user.
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
-
Multi user License
A license granted to multiple users.
-
Site License
A license granted to a single business site/establishment.
-
Corporate License, Global License
A license granted to all employees within organisation access to the product.
-
Immediate / Within 24-48 hours - Working days
-
Online Payments with PayPal and CCavenue
-
You can order a report by picking any of the payment methods which is bank wire or online payment through any Debit/Credit card or PayPal.
-
Email
-
Hard Copy